PMID- 36385451 OWN - NLM STAT- MEDLINE DCOM- 20240119 LR - 20240305 IS - 1868-601X (Electronic) IS - 1868-4483 (Linking) VI - 15 IP - 1 DP - 2024 Feb TI - Aerobic Glycolysis Induced by mTOR/HIF-1alpha Promotes Early Brain Injury After Subarachnoid Hemorrhage via Activating M1 Microglia. PG - 1-15 LID - 10.1007/s12975-022-01105-5 [doi] AB - M1 microglial activation is crucial for the pathogenesis of early brain injury (EBI) following subarachnoid hemorrhage (SAH), and there is growing evidence that glucose metabolism is frequently involved in microglial activation. However, the molecular mechanism of glycolysis and its role in M1 microglial activation in the context of EBI are not yet fully understood. In this study, firstly, the relationship between aerobic glycolysis and M1 microglial activation as well as SAH-induced EBI was researched in vivo. Then, intervention on mammalian target of rapamycin (mTOR) was performed to investigate the effects on glycolysis-dependent M1 microglial activation and EBI and its relationship with hypoxia-inducible factor-1alpha (HIF-1alpha) in vivo. Next, Hif-1alpha was inhibited to analyze its role in aerobic glycolysis, M1 microglial activation, and EBI in vivo. Lastly, both in vivo and in vitro, mTOR inhibition and Hif-1alpha enhancement were administered simultaneously, and the combined effects were further confirmed again. The results showed that aerobic glycolysis and M1 microglial polarization were increased after SAH, and glycolytic inhibition could attenuate M1 microglial activation and EBI. Inhibition of mTOR reduced glycolysis-dependent M1 microglial polarization and EBI severity by down-regulating HIF-1alpha expression, while enhancement had the opposite effects. Blockading HIF-1alpha had the similar effects as suppressing mTOR, while HIF-1alpha agonist worked against mTOR antagonist when administered simultaneously. In conclusion, the present study showed new evidence that aerobic glycolysis induced by mTOR/HIF-1alpha might promote EBI after SAH by activating M1 microglia. This finding provided new insights for the treatment of EBI. CI - (c) 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Sun, Xin-Gang AU - Sun XG AD - Department of Neurology, The Second Hospital Affiliated to Shanxi Medical University, Taiyuan, 030000, Shanxi, China. sunyanxia820701@163.com. FAU - Chu, Xue-Hong AU - Chu XH AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. FAU - Godje Godje, Ivan Steve AU - Godje Godje IS AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. FAU - Liu, Shao-Yu AU - Liu SY AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. FAU - Hu, Hui-Yu AU - Hu HY AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. FAU - Zhang, Yi-Bo AU - Zhang YB AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. FAU - Zhu, Li-Juan AU - Zhu LJ AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. FAU - Wang, Hai AU - Wang H AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. FAU - Sui, Chen AU - Sui C AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. FAU - Huang, Juan AU - Huang J AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. FAU - Shen, Ying-Jie AU - Shen YJ AD - Shanxi Medical University, Taiyuan, 030000, Shanxi, China. LA - eng GR - 201903D321044/Shanxi Province's Great Research Project/ GR - 2019045/Shanxi Health Committee's Project/ GR - 20210302123264/Shanxi Province's Basic Research Plan/ PT - Journal Article DEP - 20221117 PL - United States TA - Transl Stroke Res JT - Translational stroke research JID - 101517297 RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) SB - IM MH - Humans MH - Signal Transduction MH - Microglia MH - *Subarachnoid Hemorrhage/metabolism MH - TOR Serine-Threonine Kinases/metabolism/pharmacology MH - *Brain Injuries/etiology MH - Glycolysis MH - Hypoxia-Inducible Factor 1, alpha Subunit/metabolism/pharmacology OTO - NOTNLM OT - Aerobic glycolysis OT - Early brain injury OT - Hif-1alpha OT - Microglia OT - Subarachnoid hemorrhage OT - mTOR EDAT- 2022/11/18 06:00 MHDA- 2024/01/19 06:42 CRDT- 2022/11/17 11:04 PHST- 2022/04/15 00:00 [received] PHST- 2022/11/12 00:00 [accepted] PHST- 2022/10/19 00:00 [revised] PHST- 2024/01/19 06:42 [medline] PHST- 2022/11/18 06:00 [pubmed] PHST- 2022/11/17 11:04 [entrez] AID - 10.1007/s12975-022-01105-5 [pii] AID - 10.1007/s12975-022-01105-5 [doi] PST - ppublish SO - Transl Stroke Res. 2024 Feb;15(1):1-15. doi: 10.1007/s12975-022-01105-5. Epub 2022 Nov 17.